- Endoscopic ultrasound-guided celiac plexus neurolysis for managing abdominal pain related with advanced cancer
-
Nakano R, Shiomi H, Ota S, Iijima H
- KMID: 2532312
- Int J Gastrointest Interv.
- 2022 Jul;11(3):126-131.
- doi: hideshio0403@gmail.com
Cancer associated abdominal pain, as typified by pancreatic cancer, has conventionally been treated with narcotic drugs, but often the severe abdominal pain is difficult to control. Endoscopic ultrasound-guided celiac plexus... -
- CITED
-
- Close
- SHARE
-
- Close
- Endoscopic Ultrasound-Guided Gastroenterostomy for Afferent Loop Syndrome
-
Shiomi H, Sakai A, Nakano R, Ota S, Kobayashi T, Masuda A, Iijima H
- KMID: 2522700
- Clin Endosc.
- 2021 Nov;54(6):810-817.
- doi: 10.5946/ce.2021.234
Afferent loop syndrome (ALS) is a mechanical obstruction of the afferent limbs after gastrectomy with gastrojejunostomy reconstruction. Patients with cancer recurrence require immediate and less invasive treatment because of their... -
- CITED
-
- Close
- SHARE
-
- Close
- Narrow-band imaging with magnifying endoscopy for Peyer's patches is useful in predicting the recurrence of remissive patients with ulcerative colitis
-
Hiyama S, Iijima H, Kawai S, Mukai A, Shiraishi , Iwatani S, Yamaguchi , Araki M, Hayashi Y, Shinzaki S, Mizushima , Tsujii M, Takehara T
- KMID: 2354949
- Intest Res.
- 2016 Oct;14(4):314-321.
- doi: 10.5217/ir.2016.14.4.314
BACKGROUND/AIMS: Peyer's patches (PPs) are aggregates of lymphoid follicles that are mainly located in the distal ileum; they play a major role in mucosal immunity. We recently reported that patients... -
- CITED
-
- Close
- SHARE
-
- Close
- The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid
-
Lee JY, Minami Y, Choi BI, Lee WJ, Chou YH, Jeong WK, Park MS, Kudo N, Lee MW, Kamata K, Iijima H, Kim SY, Numata K, Sugimoto K, Maruyama H, Sumino Y, Ogawa C, Kitano M, Joo I, Arita J, Liang JD, Lin HM, Nolsoe C, Gilja OH, Kudo M
- KMID: 2503188
- Ultrasonography.
- 2020 Jul;39(3):191-220.
- doi: 10.14366/usg.20057
The first edition of the guidelines for the use of ultrasound contrast agents was published in 2004, dealing with liver applications. The second edition of the guidelines in 2008 reflected... -
- CITED
-
- Close
- SHARE
-
- Close
- Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries
-
Kobayashi , Hisamatsu , Suzuki Y, Ogata H, Andoh A, Araki T, Hokari R, Iijima H, Ikeuchi H, Ishiguro Y, Kato S, Kunisaki R, Matsumoto , Motoya S, Nagahori M, Nakamura S, Nakase H, Tsujikawa , Sasaki M, Yokoyama K, Yoshimura , Watanabe K, Katafuchi , Watanabe M, Hibi T
- KMID: 2417669
- Intest Res.
- 2018 Apr;16(2):168-177.
- doi: 10.5217/ir.2018.16.2.168
Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disease of the gastrointestinal tract, with increasing prevalence worldwide. IBD Ahead is an international... -
- CITED
-
- Close
- SHARE
-
- Close
- Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
-
Liu C, You H, Zeng QL, Wong YJ, Wang B, Grgurevic I, Liu C, Yim HJ, Gou W, Dong B, Ju S, Guo Y, Yu Q, Hirooka M, Enomoto H, Hanafy AS, Cao Z, Dong X, LV J, Kim TH, Koizumi Y, Hiasa Y, Nishimura T, Iijima H, Xu C, Dai E, Lan X, Lai C, Liu S, Wang F, Guo Y, Lv J, Zhang L, Wang Y, Xie Q, Shao C, Liu Z, Ravaioli F, Colecchia A, Li J, Teng GJ, Qi X
- KMID: 2563414
- Clin Mol Hepatol.
- 2025 Jan;31(1):105-118.
- doi: 10.3350/cmh.2024.0198
Backgrounds/Aims: Non-invasive models stratifying clinically significant portal hypertension (CSPH) are limited. Herein, we developed a new non-invasive model for predicting CSPH in patients with compensated cirrhosis and investigated whether carvedilol... -
- CITED
-
- Close
- SHARE
-
- Close
